Precision BioSciences, Inc.
DTIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $69 | $49 | $25 | $116 |
| % Growth | 41% | 94.1% | -78.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $69 | $49 | $25 | $116 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $60 | $53 | $46 | $115 |
| G&A Expenses | $35 | $39 | $41 | $40 |
| SG&A Expenses | $35 | $39 | $41 | $40 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $95 | $92 | $87 | $155 |
| Operating Income | -$26 | -$44 | -$62 | -$39 |
| % Margin | -38.1% | -89.8% | -248.3% | -34.1% |
| Other Income/Exp. Net | $33 | $1 | -$11 | $9 |
| Pre-Tax Income | $7 | -$43 | -$73 | -$31 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $7 | -$61 | -$112 | -$31 |
| % Margin | 10.4% | -125.8% | -444.8% | -26.5% |
| EPS | 1.05 | -15.96 | -38.1 | -15.6 |
| % Growth | 106.6% | 58.1% | -144.2% | – |
| EPS Diluted | 1.04 | -15.96 | -38.1 | -15.6 |
| Weighted Avg Shares Out | 7 | 4 | 3 | 2 |
| Weighted Avg Shares Out Dil | 7 | 4 | 3 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $8 | $3 | $0 |
| Interest Expense | $2 | $2 | $1 | $0 |
| Depreciation & Amortization | $5 | $8 | $9 | $10 |
| EBITDA | $14 | -$32 | -$63 | -$20 |
| % Margin | 19.7% | -65.8% | -250.2% | -17.5% |